Checkpoint Therapeutics Inc Stock Other OTC
Equities
US1628281073
Biotechnology & Medical Research
Sales 2024 * | 888K 1.22M | Sales 2025 * | 172M 236M | Capitalization | 58.17M 79.83M |
---|---|---|---|---|---|
Net income 2024 * | -51M -69.99M | Net income 2025 * | 61M 83.71M | EV / Sales 2024 * | 65.5 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-1.09
x | P/E ratio 2025 * |
1.13
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.32% |
Managers | Title | Age | Since |
---|---|---|---|
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
William Gray
DFI | Director of Finance/CFO | 36 | 16-01-31 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-09 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Christian Béchon
BRD | Director/Board Member | 63 | 18-10-15 |
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |